Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a Passover gift and support Jewish journalism. DONATE NOW
Culture

Reclusive Marvel CEO Ike Perlmutter Suing Over Stolen DNA

You’d be forgiven for not knowing of Ike Perlmutter, even though he is the CEO of Marvel Entertainment; the Israeli-born executive is a notorious recluse. For a recluse, particularly a powerful and wealthy businessman, all theft is an immense transgression – even the theft of DNA. You read that right, Perlmutter is alleging that someone stole his DNA. With the recently granted permission of a Florida judge, Perlmutter’s DNA is at the center of an outlandish lawsuit that could have important legal ramifications.

The Hollywood Reporter has done excellent reporting on this case; for their full report, read this article, and this one. Here are the basics: Perlmutter is suing a man named Harold Peerenboom for allegedly stealing his DNA.

The Hollywood Reporter writes that, according to circuit judge Meenu Sasser, “no binding authority has ever definitively answered the question of whether genetic material such as DNA constitutes ‘property.’” There are a couple reasons that Perlmutter – or anyone else – might be worried about the theft of his DNA, besides a violation of privacy. If the theft is used to glean any sort of medical information, it could be used to reveal potentially damaging medical secrets to an employer or the public . The information taken from a DNA sample could also be used for defamation or blackmail, as in, for example, a case of disputed paternity.

The DNA theft, Perlmutter alleges, occurred during a deposition for a separate lawsuit. That other lawsuit is a defamation case Peerenboom brought against Perlmutter alleging the latter sent damaging letters to his family and friends, which, among other things, accused Peerenboom of being a sex offender and Nazi sympathizer. If all of this sounds bizarre and convoluted, that’s because it is.

For the full report, and it’s a doozy, check out the two aforementioned The Hollywood Reporter articles.

Jake Romm is the Forward’s culture intern. Contact him at [email protected]

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news this Passover. All donations are being matched by the Forward Board - up to $100,000.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give this Passover is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.